This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Antiplatelet therapy in primary care - primary prevention of cardiovascular disease (CVD)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Antiplatelet therapy in primary care with respect to primary prevention of cardiovascular disease:

  • low-dose aspirin (75mg daily) should be considered for all patients over the age of 50 at high risk of coronary heart disease (CHD) (10-year CHD risk of 15% or more) provided hypertension is controlled
  • clopidogrel and MR-dipyridamole are not indicated or licensed for primary prevention of CV events

Reference:

  1. MeReC Bulletin 2005; 15(6):21-4.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.